WECHE Inhibitors

Chemical inhibitors of WECHE function by modulating the activity of matrix metalloproteases (MMPs) and related enzymes that are essential for the remodeling of the extracellular matrix, a process in which WECHE is involved. Marimastat and GM6001, also known as Ilomastat, act as broad-spectrum MMP inhibitors. These inhibitors directly decrease the breakdown of extracellular matrix components by targeting a wide range of MMPs. The reduced degradation of the matrix can alter the microenvironment and inhibit the release or activation of molecules interacting with WECHE. Batimastat and its synonym BB-94 also fall into this category, providing a similar inhibitory effect on MMPs, including MMP-1, MMP-2, MMP-9, and MMP-7, which are key to the matrix remodeling associated with WECHE's functional role.

SB-3CT, which appears twice in the list due to a clerical duplication, is a selective inhibitor of MMP-2 and MMP-9. By focusing on these specific MMPs, SB-3CT ensures a targeted approach to inhibiting the extracellular matrix turnover, which is important for WECHE's function. TAPI-0, on the other hand, inhibits the tumor necrosis factor-alpha converting enzyme (TACE) that is involved in the shedding of cell surface molecules. This inhibition can prevent the cleavage of membrane-bound precursors that may be necessary for WECHE's activity. PD166793 and Ro 32-3555 provide further inhibition of MMPs, with PD166793 being selective for certain MMPs, thereby reducing the matrix remodeling that WECHE relies on. Ro 28-2653, which targets MMP-2, MMP-9, and MMP-14, acts in a similar manner to reduce matrix turnover. Lastly, Prinomastat targets MMPs that are involved in processes such as angiogenesis, which are crucial for the correct functioning of WECHE, ensuring that the extracellular conditions required for WECHE's activity are maintained at a state that limits its function.